Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Prophylaxis”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Early research (Phase 1)Looking for participantsNCT07199465
What this trial is testing

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

Who this might be right for
Cytomegalovirus Prophylaxis
Merck Sharp & Dohme LLC 40
Not applicableStudy completedNCT00002299
What this trial is testing

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Not applicableUnknownNCT02973464
What this trial is testing

The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population

Who this might be right for
Renal Transplant Recipients
First Affiliated Hospital Xi'an Jiaotong University 450
Post-approval studies (Phase 4)Study completedNCT01446445
What this trial is testing

Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.

Who this might be right for
Infection in Solid Organ Transplant Recipients
Nuria Lloberas 60
Not applicableStudy completedNCT02784756
What this trial is testing

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Viraemia
University Health Network, Toronto 134
Testing effectiveness (Phase 2)Looking for participantsNCT06575374
What this trial is testing

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Who this might be right for
Cell Therapy
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT04312841
What this trial is testing

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaPeripheral T-Cell Lymphoma+3 more
Ohio State University Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01972035
What this trial is testing

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

Who this might be right for
Transplantation InfectionEpstein-Barr Virus InfectionsCytomegalovirus Infections
University of Minnesota 137
Testing effectiveness (Phase 2)Study completedNCT03486834
What this trial is testing

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Who this might be right for
Cytomegalovirus (CMV) Infections
Merck Sharp & Dohme LLC 2,200
Large-scale testing (Phase 3)Study completedNCT00497796
What this trial is testing

Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

Who this might be right for
Cytomegalovirus Infections
Shire 307
Not applicableActive Not RecruitingNCT01199562
What this trial is testing

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated Leukemia+151 more
City of Hope Medical Center 153
Testing effectiveness (Phase 2)Looking for participantsNCT04056533
What this trial is testing

Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy

Who this might be right for
CMV
Instituto de Investigación Marqués de Valdecilla 15
Large-scale testing (Phase 3)Study completedNCT02137772
What this trial is testing

Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)

Who this might be right for
Prevention of CMV Infection or Disease
Merck Sharp & Dohme LLC 570
Not applicableLooking for participantsNCT07013370
What this trial is testing

Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Immunoglobulin ProphylaxisCytomegalovirus InfectionsAllogeneic Hematopoietic Stem Cell Transplantation+1 more
Antonello Di Paolo, M.D., Ph.D. 150
Early research (Phase 1)Study completedNCT01070797
What this trial is testing

Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)

Who this might be right for
Adenovirus InfectionEpstein-Barr Virus InfectionsCytomegalovirus Infections+1 more
Baylor College of Medicine 10
Not applicableStudy completedNCT00170170
What this trial is testing

Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation

Who this might be right for
TransplantationInfectionCytomegalovirus Infections
Mayo Clinic 500
Not applicableLooking for participantsNCT07294547
What this trial is testing

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Who this might be right for
Kidney Transplantation, Cytomegalovirus InfectionsEBV InfectionAntiviral Prophylaxis
National Taiwan University Hospital 80
Not applicableStudy completedNCT04906304
What this trial is testing

Comparison of Safety and Efficacy of de Novo Everolimus

Who this might be right for
Cytomegalovirus Infections
Shahid Beheshti University of Medical Sciences 35
Early research (Phase 1)UnknownNCT03576014
What this trial is testing

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

Who this might be right for
Cytomegalovirus InfectionsPreventation of Cytomegalovirus ReactivationBK Virus Infection+1 more
SL VAXiGEN 18
Testing effectiveness (Phase 2)Looking for participantsNCT05432778
What this trial is testing

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

Who this might be right for
CMV Viremia
University Medical Centre Ljubljana 90
Load More Results